Nadda leads MPs from Karnataka & Kerala to accelerate TB-free India campaign

केंद्रीय स्वास्थ्य मंत्री श्री जे. पी. नड्डा ने कर्नाटक और केरल के सांसदों के साथ चर्चा की अध्यक्षता की, जिससे टीबी-मुक् — labelled illustration

Nadda leads MPs from Karnataka & Kerala to accelerate TB-free India campaign

3D cutaway: केंद्रीय स्वास्थ्य मंत्री श्री जे. पी. नड्डा ने कर्नाटक और केरल के सांसदों के साथ चर्चा की
3D cutaway: केंद्रीय स्वास्थ्य मंत्री श्री जे. पी. नड्डा ने कर्नाटक और केरल के सांसदों के साथ चर्चा की

✎ The ‘TB-Mukt Bharat Abhiyaan’ is a 100-day, two-phase campaign under NTEP that intensified TB case detection and treatment in 347 high-priority districts and 1.58 lakh high-risk villages/urban wards.

Subject Relevance — Where This Topic Fits

  • GS Paper II — Governance, Constitution, Polity, Social Justice and International Relations (Health Governance)  |  GS Paper III — Science and Technology (Public Health), Environment and Disaster Management (Disease Control)
  • Prelims: National Tuberculosis Elimination Programme (NTEP), Sustainable Development Goals (SDG 3.3), Directly Observed Treatment Short-course (DOTS), Nikshay Poshan Yojana, Revised National Tuberculosis Control Programme (RNTCP), TB-Mukt Bharat Abhiyaan, Parliamentary Standing Committee on Health, District Collectors, Nikshay 2.0 portal
  • Essay: Health as a Public Good: The Case for Universal Healthcare Coverage, The Role of Political Will in Achieving Sustainable Development Goals

Quick Revision: The ‘TB-Mukt Bharat Abhiyaan’ is a 100-day, two-phase campaign under NTEP that intensified TB case detection and treatment in 347 high-priority districts and 1.58 lakh high-risk villages/urban wards.

Why is this in the news?

The Union Health Minister chaired a high-level meeting with Members of Parliament from Karnataka and Kerala to review progress under the ‘TB-Mukt Bharat Abhiyaan’ and strategise for accelerated tuberculosis elimination, highlighting the integration of parliamentary oversight with district-level implementation mechanisms and community engagement.

Background

  • Tuberculosis (TB) remains a significant public health challenge in India, accounting for approximately 27% of the global TB burden despite being preventable and curable.
  • The National Tuberculosis Elimination Programme (NTEP), previously known as RNTCP, has undergone multiple revisions to align with the End TB Strategy of the World Health Organization.
  • The ‘TB-Mukt Bharat Abhiyaan’ is a flagship initiative under NTEP, operationalised through two phases of the 100-Day Campaign, focusing on high-risk districts, villages, and urban wards to intensify case detection and treatment adherence.
  • Parliamentary engagement in health governance has been institutionalised through consultative meetings with MPs to foster multi-stakeholder collaboration and ensure accountability in public health delivery.
  • The meeting underscores the role of elected representatives in bridging the gap between national policy and grassroots implementation, particularly in states with high TB prevalence.

What is the ‘TB-Mukt Bharat Abhiyaan’ and its Governance Framework?

  • The ‘TB-Mukt Bharat Abhiyaan’ is a time-bound, mission-mode campaign under the National Tuberculosis Elimination Programme (NTEP) to accelerate India’s progress towards TB elimination by 2025.
  • The campaign operates through a two-phase 100-day model: Phase I started on 7 December 2024 and ended on 24 March 2025, targeting 347 high-priority districts, while Phase II started on 24 March 2026 and ended in July 2026, expanding to cover 1.58 lakh high-risk villages and urban wards across India.
  • Key objectives include early case detection, ensuring 100% treatment coverage, reducing TB-related mortality, and addressing social determinants such as malnutrition and stigma through multi-sectoral interventions.
  • The campaign leverages innovative patient-identification strategies, including community-based screening, digital tools (e.g., Nikshay 2.0 portal), and active case-finding in high-risk populations such as tribal communities, urban slums, and migrant workers.
  • Parliamentary involvement is structured through consultative meetings with MPs to review progress, identify implementation bottlenecks, and foster district-level coordination with health authorities and district collectors.
  • The campaign integrates patient-centric care models, including nutritional support under the Nikshay Poshan Yojana, counselling for treatment adherence, and post-treatment follow-up to prevent relapse and drug-resistant TB.
  • India’s TB elimination strategy aligns with the WHO’s End TB Strategy, focusing on three pillars: integrated patient-centred care and prevention, bold policies and supportive systems, and intensified research and innovation.
  • The campaign’s success metrics include the number of TB cases detected, treatment success rates, reduction in TB mortality, and community awareness levels, with real-time monitoring through the Nikshay platform.

Key Features

Feature Significance
100-Day TB-Mukt Bharat Campaign (Phase II) Accelerated case detection and treatment initiation through intensified screening in high-risk villages and urban wards, covering 1.58 lakh locations nationwide.
Patient-Centric Care Model Shift from provider-driven to patient-focused TB care, ensuring dignity, adherence support, and post-treatment follow-up for improved outcomes.
Multi-Stakeholder Coordination Involvement of district collectors, health institutions, and MPs to bridge gaps between policy and ground-level implementation.
Innovative Case-Finding Strategies Use of AI-driven algorithms, digital health records, and community-led surveillance to identify undetected TB cases.
Political Ownership through MPs Sustained parliamentary engagement to prioritize TB elimination, align resources, and foster public-private partnerships.

Why it Matters

Public Health Impact

  • Demonstrates India’s accelerated progress toward WHO’s End TB Strategy, with a 21% reduction in TB cases (2015–2024) and 92% treatment coverage.
  • Reduces disease burden, economic losses (estimated at 1.5% of GDP annually), and mortality, particularly among vulnerable populations.
  • Strengthens India’s global leadership in TB elimination, aligning with Sustainable Development Goal 3.3.

Governance & Institutional Strengthening

  • Showcases the ‘Whole-of-Government’ approach, integrating health, rural development, and local governance for holistic TB control.
  • Enhances inter-departmental synergy (e.g., education for awareness, MSME for livelihood support for recovered patients).
  • Establishes a precedent for parliamentary oversight in public health emergencies.

Socio-Economic Benefits

  • Prevents loss of productivity by enabling early diagnosis and treatment, particularly in high-risk demographic groups.
  • Reduces out-of-pocket expenditure for households affected by TB, improving financial inclusion.
  • Supports SDG targets on poverty reduction (SDG 1) and decent work (SDG 8) by mitigating TB’s economic impact.

Challenges

1. Diagnostic Gaps in Hard-to-Reach Areas

  • Persistent under-detection in tribal, remote, and urban slum populations due to limited healthcare access.
  • Need for mobile diagnostic units and community health workers to bridge last-mile delivery gaps.

2. Drug-Resistant TB (DR-TB) Management

  • Rising prevalence of multi-drug-resistant TB (MDR-TB) requires advanced diagnostics and longer, costlier treatment regimens.
  • Ensuring uninterrupted drug supply and adherence support to prevent treatment failure.

3. Stigma and Low Awareness

  • Social stigma discourages TB reporting, leading to delayed diagnosis and treatment.
  • Requires sustained IEC (Information, Education, Communication) campaigns to dispel myths and promote early care-seeking.

4. Private Sector Engagement

  • Inadequate reporting and non-standard treatment by private practitioners undermines national TB control efforts.
  • Mandatory notification under the Nikshay portal and incentives for compliant providers are critical.

5. Data Integration and Surveillance

  • Fragmented health data systems hinder real-time monitoring of TB trends and program performance.
  • Strengthening the Ni-Kshay platform and interoperability with Ayushman Bharat Digital Mission (ABDM) is essential.

6. Funding and Resource Mobilisation

  • Sustained financing for TB programs amid competing health priorities requires innovative financing models.
  • Exploring public-private partnerships and global health funding mechanisms (e.g., Global Fund to Fight AIDS, TB, and Malaria).

Challenges — UPSC Perspective

Issue Concern
Under-Reporting in Private Sector Non-compliance with mandatory TB notification leads to gaps in national data.
MDR-TB Prevalence Higher treatment costs and longer durations strain health systems and patient adherence.
Geographical Disparities Hilly, tribal, and urban slum areas face inadequate diagnostic and treatment facilities.
Stigma and Discrimination Delays in care-seeking due to fear of social ostracization.
Supply Chain Bottlenecks Irregular availability of TB drugs and diagnostics in peripheral health centers.

Government Initiatives — Must-Memorise for Prelims

  • Nikshay Poshan Yojana (Nutritional support for TB patients)
  • Ayushman Bharat Health and Wellness Centres (AB-HWCs) for TB screening

Way Forward

  • Scale up mobile diagnostic units and telemedicine services in high-risk districts to improve early detection.
  • Strengthen the Ni-Kshay platform with real-time data analytics for targeted interventions and monitoring.
  • Expand mandatory TB notification compliance among private healthcare providers through incentives and penalties.
  • Launch region-specific awareness campaigns in tribal, coastal, and urban slum areas to combat stigma.
  • Enhance DR-TB management by scaling up rapid molecular diagnostics (e.g., CBNAAT, TruNat) and shorter treatment regimens.
  • Integrate TB screening with existing health programs (e.g., Ayushman Bharat, Poshan Abhiyaan) for comprehensive coverage.
  • Foster public-private partnerships to leverage corporate social responsibility (CSR) funds for TB elimination initiatives.
  • Conduct periodic state-wise reviews with district collectors and MPs to ensure accountability and resource allocation.

UPSC Value Addition

Keywords for Mains Answer-Writing

Tuberculosis elimination · National Strategic Plan for TB Elimination · 100-Day TB-Mukt Bharat Abhiyaan · Patient-centric TB care · Multi-stakeholder convergence · District-level monitoring · Community engagement · WHO Global TB Report 2025 · TB treatment coverage · High-burden districts · Parliamentary role in public health · Innovative case-finding strategies

Concept Flow

High TB burden in India → Recognition as a public health emergency → Formulation of National Strategic Plan (NSP) for TB Elimination → Launch of 100-Day TB-Mukt Bharat Campaign → Multi-stakeholder coordination (MPs, district collectors, health institutions) → Intensified case-finding and patient-centric care → Reduction in TB incidence and mortality → Alignment with SDG 3.3 (Good Health and Well-being) → Global recognition of India’s progress.

Prelims Practice Questions

Q1. Consider the following statements regarding the 100-Day TB-Mukt Bharat Abhiyaan:
1. The first phase covered 347 high-priority districts.
2. The second phase included approximately 1.58 lakh high-risk villages and urban wards.
3. The campaign screened over 2.02 crore individuals and detected 7 lakh new TB cases.

How many of the above statements are correct?

  1. Only one
  2. Only two
  3. All three
  4. None

Answer: All three — Statement 1 and 2 are correct as per the official data. Statement 3 is incorrect; the campaign screened 2.02 crore individuals but detected 7 lakh new TB cases, which is not explicitly stated as a screening figure.

Q2. Assertion (A): The National Strategic Plan for TB Elimination aims for a 95% reduction in TB incidence by 2025.
Reason (R): The plan prioritizes patient-centric care and innovative case-finding strategies to achieve its goals.

Options:
A. Both A and R are true, and R is the correct explanation of A.
B. Both A and R are true, but R is not the correct explanation of A.
C. A is true, but R is false.
D. A is false, but R is true.

    Answer: ? — Assertion (A) is false; the National Strategic Plan targets a 90% reduction in TB incidence by 2025, not 95%. Reason (R) is true and aligns with the plan’s approach.

    Q3. Match the following phases of the TB-Mukt Bharat Abhiyaan with their respective timelines:

    Column I (Phase) | Column II (Timeline)
    ——————————–|————————
    1. First Phase | A. 24 March 2026 – 4 July 2026
    2. Second Phase | B. 7 December 2024 – 24 March 2025

    Options:
    A. 1-B, 2-A
    B. 1-A, 2-B
    C. 1-A, 2-A
    D. 1-B, 2-B

      Answer: ? — The first phase of the 100-Day TB-Mukt Bharat Abhiyaan ran from 7 December 2024 to 24 March 2025, while the second phase operated from 24 March 2026 to 4 July 2026.

      Mains Practice Question

      ✍ The Union Government’s ‘TB-Mukt Bharat Abhiyaan’ represents a multi-dimensional approach to tuberculosis elimination through innovation, patient-centric care, and multi-stakeholder convergence. Critically examine the strategic pillars of this initiative and evaluate its progress in the context of the WHO Global TB Report 2025. (15 Marks)

      Approach: MODEL-ANSWER SKELETON:

      1. **Strategic Pillars of TB-Mukt Bharat Abhiyaan** (6 points, 100 words):
      – **Patient-centric care**: Emphasis on dignity, support systems, and reducing stigma (align with National Strategic Plan for TB Elimination 2017–2025).
      – **Innovative case-finding**: Use of AI-driven screening, digital health records, and community-based detection (cite examples like Nikshay Poshan Yojana and Nikshay Mitra).
      – **Multi-stakeholder convergence**: Integration of Parliamentarians, district collectors, ASHAs, and NGOs for ground-level implementation (reference today’s meeting with MPs from Karnataka and Kerala).
      – **100-Day Campaigns**: Phased implementation with measurable targets (first phase: 347 high-burden districts; second phase: 1.58 lakh high-risk villages/wards).
      – **Data-driven monitoring**: Real-time dashboards, district-level accountability, and periodic reviews (reference role of District Collectors and health institutions).
      – **Community engagement**: Jan Andolan for TB elimination, leveraging local leaders and influencers.

      2. **Progress Evaluation** (6 points, 100 words):
      – **Treatment coverage**: 92% achieved (WHO Global TB Report 2025), exceeding the global average.
      – **Incidence reduction**: 21% decline from 2015–2024, nearly double the global pace (WHO data).
      – **Challenges**: Persistent gaps in urban slums, migrant populations, and drug-resistant TB; need for sustained political will.
      – **Comparative advantage**: India’s progress outpaces high-burden countries like Indonesia and Nigeria (WHO 2025).
      – **Role of Parliamentarians**: Today’s meeting highlights their function as ‘agents of change’ in public health governance.
      – **Future roadmap**: Scaling up preventive therapy, addressing social determinants, and strengthening health systems.

      3. **Critical Perspective** (3 points, 50 words):
      – **Strengths**: Scalability, innovation, and convergence model.
      – **Limitations**: Over-reliance on campaigns; need for systemic integration.
      – **Way forward**: Institutionalize multi-stakeholder models beyond ad-hoc initiatives.

      Source: PIB (Press Information Bureau)


      Generated by AanyaAi for educational purpose.

      No Comments

      Post A Comment